Table 5. Association of Talking to Customers About Risk With State Medicalization Score and Statewide Adult Use^a.

Risk	State medicalization score (per 10-point increment)		Statewide adult use
	B (SE)	P value	B (SE)	P value
Cannabis use disorder/addiction	0.003 (0.04)	.95	−0.2 (0.13)	.12
Motor vehicle collisions/safe driving	0.02 (0.05)	.61	0.04 (0.15)	.80
Cannabis withdrawal symptoms	−0.04 (0.04)	.34	−0.21 (0.13)	.10
Psychotic reaction	0.03 (0.06)	.51	−0.02 (0.07)	.79
Cannabis medication interactions	0.08 (0.05)	.09	−0.16 (0.15)	.3
Potential cannabis adverse effects (eg, sleepiness, paranoia)	0.01 (0.04)	.75	−0.17 (0.13)	.18
Safe storage away from children and pets	0.04 (0.04)	.36	0.3 (0.13)	.03

^aThis table presents a series of linear regression models in which each row represents the dependent variable with each column representing an independent variable in separate linear regression models. For example, the top-left-hand cell indicates that a 10-point increase in the state medicalization score is associated with a mean change of 0.003 in the scale response to how often the respondent talks to their customers about the risks of cannabis use disorder/addiction.